The store will not work correctly when cookies are disabled.
4-methyl-N-(3-(trifluoromethyl)phenyl)benzenesulfonamide
ID: ALA1170012
Cas Number: 1584-58-3
PubChem CID: 837245
Max Phase: Preclinical
Molecular Formula: C14H12F3NO2S
Molecular Weight: 315.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)cc1
Standard InChI: InChI=1S/C14H12F3NO2S/c1-10-5-7-13(8-6-10)21(19,20)18-12-4-2-3-11(9-12)14(15,16)17/h2-9,18H,1H3
Standard InChI Key: LAQWXSZWFLYJOE-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
-2.7976 1.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7988 0.2575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0838 -0.1556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3670 0.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3715 1.0914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0855 1.4979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6568 1.5040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0578 1.0914 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.4704 1.8061 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3548 0.3767 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7725 0.6788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7700 -0.1435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4827 -0.5527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1945 -0.1398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1897 0.6851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4779 1.0905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0838 -0.9809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9093 -0.9809 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.2588 -0.9809 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.0838 -1.8061 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.9093 -0.5525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
8 11 1 0
5 6 2 0
11 12 2 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 2 0
5 7 1 0
14 15 1 0
3 4 2 0
15 16 2 0
16 11 1 0
7 8 1 0
3 17 1 0
17 18 1 0
8 9 2 0
17 19 1 0
4 5 1 0
17 20 1 0
8 10 2 0
14 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.32 | Molecular Weight (Monoisotopic): 315.0541 | AlogP: 3.81 | #Rotatable Bonds: 3 |
Polar Surface Area: 46.17 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.94 | CX Basic pKa: ┄ | CX LogP: 3.85 | CX LogD: 3.76 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.94 | Np Likeness Score: -1.95 |
References
1. Caridha D, Kathcart AK, Jirage D, Waters NC.. (2010) Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases., 20 (13): [PMID:20627564] [10.1016/j.bmcl.2010.05.039] |
2. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |